Evaluation of Quantum Dots Nanobeads Based Lateral Flow Immunoassay for Interluekin-6 Detection in Human Blood for Cervical Inflammation Monitoring

References

[1] World Health Organization. Cervical Cancer [Internet]. Geneva: World Health Organization; 2024 Mar 5 [cited 2024 Mar 5]. Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer

[2] Han S, Lin M, Liu M, Wu S, Guo P, Guo J, et al. Prevalence, trends, and geographic distribution of human papillomavirus infection in Chinese women: a summative analysis of 2,728,321 cases. BMC Med. 2025;23(1):158.

[3] Li Q, Liu KD, Tian Z, Diao W, Sun Y, Bai Y, et al. Association of Inflammatory Factors with Cervical Cancer: A Bidirectional Mendelian Randomization. J Inflamm Res. 2024;17:10119-30.

[4] Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020;40(5):602-8.

[5] Cai C, Peng X, Zhang Y. Serum IL-6 Level Predicts the Prognosis and Diagnosis in Cervical Cancer Patients. Int J Womens Health. 2022;14:655-63.

[6] Obeagu EI. Modulation of Chronic Cytokine Dysregulation in Cervical Cancer: Potential Biomarkers and Therapeutic Targets. Cancer Manag Res. 2025;17:1113-26.

[7] Song Z, Lin Y, Ye X, Feng C, Lu Y, Yang G, et al. Expression of IL-1α and IL-6 is Associated with Progression and Prognosis of Human Cervical Cancer. Med Sci Monit. 2016;22:4475-81.

[8] Tanaka T, Narazaki M, Kishimoto T. IL-6 in Inflammation, Immunity, and Disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295.

[9] Hou S, Ma J, Cheng Y, Wang H, Sun J, Yan Y. Quantum dot nanobead-based fluorescent immunochromatographic assay for simultaneous quantitative detection of fumonisin B1, dexyonivalenol, and zearalenone in grains. Food Control. 2020;117:107331.